TheraRadar
← Back
Data updated: Mar 29, 2026

WATSON LABS TEVA

CardiovascularNeurologyImmunology
Generics

WATSON LABS TEVA is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology.

1974
Since
45
Drugs
-
Trials
281
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 43%
6 drugs
Neurology 14%
2 drugs
Immunology 14%
2 drugs
Metabolic 14%
2 drugs
Gastroenterology 14%
2 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...